BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17184724)

  • 1. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates.
    Gouvea IE; Izidoro MA; Judice WA; Cezari MH; Caliendo G; Santagada V; dos Santos CN; Queiroz MH; Juliano MA; Young PR; Fairlie DP; Juliano L
    Arch Biochem Biophys; 2007 Jan; 457(2):187-96. PubMed ID: 17184724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever virus NS2B/NS3 protease: hydrolytic properties and substrate specificity.
    Kondo MY; Oliveira LC; Okamoto DN; de Araujo MR; Duarte dos Santos CN; Juliano MA; Juliano L; Gouvea IE
    Biochem Biophys Res Commun; 2011 Apr; 407(4):640-4. PubMed ID: 21419753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
    Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
    Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
    Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
    Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH; Yon C; Ganesh VK; Padmanabhan R
    Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM; Judge K; DeLucas L; Padmanabhan R
    J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled peptide solvation in portion-mixing libraries of FRET peptides: improved specificity determination for Dengue 2 virus NS2B-NS3 protease and human cathepsin S.
    Alves FM; Hirata IY; Gouvea IE; Alves MF; Meldal M; Brömme D; Juliano L; Juliano MA
    J Comb Chem; 2007; 9(4):627-34. PubMed ID: 17563123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease.
    Konstantinidis AK; Richardson PL; Kurtz KA; Tripathi R; Chen CM; Huang P; Randolph J; Towne D; Donnelly J; Warrior U; Middleton T; Kati WM
    Anal Biochem; 2007 Sep; 368(2):156-67. PubMed ID: 17644059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H; Singh NJ; Kim KS
    Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The active essential CFNS3d protein complex.
    Melino S; Fucito S; Campagna A; Wrubl F; Gamarnik A; Cicero DO; Paci M
    FEBS J; 2006 Aug; 273(16):3650-62. PubMed ID: 16911516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
    Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
    Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Knox JE; Ma NL; Ehrhardt C; Lim SP; Vasudevan SG; Keller TH
    Bioorg Med Chem Lett; 2006 Jan; 16(1):40-3. PubMed ID: 16246563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
    Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.
    Zuo Z; Liew OW; Chen G; Chong PC; Lee SH; Chen K; Jiang H; Puah CM; Zhu W
    J Virol; 2009 Jan; 83(2):1060-70. PubMed ID: 18971276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and in-cell selectivity profiling of the full-length West Nile virus NS2B/NS3 serine protease using membrane-anchored fluorescent substrates.
    Condotta SA; Martin MM; Boutin M; Jean F
    Biol Chem; 2010 May; 391(5):549-59. PubMed ID: 20302513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study.
    Yotmanee P; Rungrotmongkol T; Wichapong K; Choi SB; Wahab HA; Kungwan N; Hannongbua S
    J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis virus NS2B-NS3 protease binding to phage-displayed human brain proteins with the domain of trypsin inhibitor and basic region leucine zipper.
    Lin CW; Lin KH; Lyu PC; Chen WJ
    Virus Res; 2006 Mar; 116(1-2):106-13. PubMed ID: 16289409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the substrate specificity of mouse cathepsin P.
    Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
    Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.